Cellectar Biosciences, Inc.
Clinical trials sponsored by Cellectar Biosciences, Inc., explained in plain language.
-
New hope for kids with relapsed cancers: experimental drug CLR 131 enters early trial
Disease control OngoingThis early-phase study tests an experimental drug called CLR 131 in children, adolescents, and young adults (ages up to 30) with certain cancers that have come back or not responded to standard treatments. The cancers include solid tumors (like neuroblastoma and sarcomas), lympho…
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC
-
Radioactive drug shows promise for Hard-to-Treat blood cancers
Disease control OngoingThis study tests an experimental radioactive drug called iopofosine I 131 in people with certain blood cancers (like Waldenstrom macroglobulinemia, multiple myeloma, and lymphoma) that have come back or not responded to standard treatments. The drug is designed to target and kill…
Phase: PHASE2 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 03:53 UTC